MedTrace Logo

The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation

NCT06348849 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-01-30

No results posted yet for this study

Summary

The aim of the current study is to assess the desensitising effect of nanosilver fluoride on first permanent molars (FPMs) in patients with MIH in comparison to low-level laser therapy.

Conditions

Interventions

DEVICE

Low-level laser therapy

Wavelength 980nm (SmartM, Lasotronix, Poland)

DRUG

Nanosilver fluoride

Optimized synthesis of Nanosilver Fluoride

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-06-01
Completion
2024-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06348849 on ClinicalTrials.gov